High-level carbapenem-resistant (CpmR) mutants, with MICs for imipenem and carbapenem of greater than 128 micrograms/ml, were selected in vitro from four carbapenem-susceptible (CpmS) clinical isolates of Bacteroides fragilis. The CpmS strains produced very low levels of beta-lactamase activity, which was increased approx. 50- to 100-fold in the CpmR mutants. Isoelectric focussing and enzyme kinetic analysis (Km and Vrel) of the 'carbapenemases' from the CpmR mutants and similarly resistant clinical isolates suggested a close relatedness of the enzymes. A probe covering most of the cfiA gene encoding such an enzyme (Thompson, J.S. and Malamy, M.H. (1990) J. Bacteriol. 172, 2584-2593) hybridized with DNA from the CpmR mutants, their CpmS parental strains as well as clinical CpmR isolates, but not from randomly chosen carbapenem-susceptible strains. The possibility is considered that mutations leading to expression of the silent carbapenemase gene, and thereby to clinically relevant carbapenem resistance, may also occur in the clinical setting.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0378-1097(92)90557-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The coat protein of tobacco mosaic virus as an anti-tobacco mosaic virus: a molecular dynamics simulation.
J Biomol Struct Dyn
December 2023
Department of Chemistry, Faculty of Science, Yazd University, Yazd, Iran.
The Coat Protein (CP) of the Tobacco Mosaic Virus (TMV) executes an important duty in the protection of virus RNA. The interaction between the virus CP and host plant proteins induces infection in the host and creates dark and light green mosaics on crops, which disturb the growth and function of the plant. The interaction between the virus CP and the modified CP, expressed in transgenic plants, causes Coat Protein-Mediated Resistance (CP-MR), which reduces virus infection in transgenic plants.
View Article and Find Full Text PDFConformational behavior of coat protein in plants and association with coat protein-mediated resistance against TMV.
Braz J Microbiol
September 2020
Biotechnology division, CSIR-IHBT, Palampur, HP, 176061, India.
Tobacco mosaic virus (TMV) coat protein (CP) self assembles in viral RNA deprived transgenic plants to form aggregates based on the physical conditions of the environment. Transgenic plants in which these aggregates are developed show resistance toward infection by TMV referred to as CP-MR. This phenomenon has been extensively used to protect transgenic plants against viral diseases.
View Article and Find Full Text PDFCoat protein-mediated resistance to TMV infection of Nicotiana tabacum involves multiple modes of interference by coat protein.
Virology
September 2007
Donald Danforth Plant Science Center, 975 N. Warson Rd., St. Louis, MO 63132, USA.
Expression of tobacco mosaic virus (TMV) coat protein (CP) restricts virus disassembly and alters the accumulation of the movement protein (MP). To characterize the role of structure of transgenic CP in regulating virus disassembly and production of MP, we generated CPs with mutations at residues Glu50 and Asp77, located in the interface between juxtaposed CP subunits. In transgenic Nicotiana tabacum and BY-2 cells, three categories of coat protein-mediated resistance (CP-MR) levels were identified: wild-type CP-MR; elevated CP-MR; and no CP-MR.
View Article and Find Full Text PDFAggregation of TMV CP plays a role in CP functions and in coat-protein-mediated resistance.
Virology
September 2007
Donald Danforth Plant Science Center, 975 North Warson Road, St. Louis, MO 63132, USA.
Tobacco mosaic virus (TMV) coat protein (CP) in absence of RNA self-assembles into several different structures depending on pH and ionic strength. Transgenic plants that produce self-assembling CP are resistant to TMV infection, a phenomenon referred to as coat-protein-mediated resistance (CP-MR). The mutant CP Thr42Trp (CP(T42W)) produces enhanced CP-MR compared to wild-type CP.
View Article and Find Full Text PDFCoat-protein-mediated resistance to tobacco mosaic virus: discovery mechanisms and exploitation.
Philos Trans R Soc Lond B Biol Sci
March 1999
Scripps Research Institute, La Jolla, CA 92037, USA.
In 1986 we reported that transgenic plants which accumulate the coat protein of tobacco mosaic virus (TMV) are protected from infection by TMV, and by closely related tobamoviruses. The phenomenon is referred to as coat-protein-mediated resistance (CP-MR), and bears certain similarities to cross protection, a phenomenon described by plant pathologists early in this century. Our studies of CP-MR against TMV have demonstrated that transgenically expressed CP interferes with disassembly of TMV particles in the inoculated transgenic cell.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!